Royalty Pharma plc
RPRX
Peringkat dalam Saham
#893
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$60.39
Kapitalisasi Pasar
$26.89B
Perubahan (1 hari)
-0.93%
Perubahan (1 tahun)
63.17%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
EPS untuk Royalty Pharma plc (RPRX)
EPS per June 2026 TTM: $2.41
Menurut laporan keuangan terbaru dan harga saham Royalty Pharma plc, EPS perusahaan saat ini (TTM) adalah $2.41. Pada akhir 2024, perusahaan memiliki EPS sebesar $1.92 penurunan dibandingkan dengan EPS tahun 2023 sebesar $2.54.
Riwayat EPS untuk Royalty Pharma plc dari 2015 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $2.41 | 34.64% |
| 2025 | $1.79 | -6.61% |
| 2024 | $1.92 | -24.41% |
| 2023 | $2.54 | 2,492.43% |
| 2022 | $0.10 | -93.45% |
| 2021 | $1.49 | -42.47% |
| 2020 | $2.60 | -59.54% |
| 2019 | $6.42 | 182.80% |
| 2018 | $2.27 | 13.86% |
| 2017 | $1.99 | 113.83% |
| 2016 | $0.93 | -2.67% |
| 2015 | $0.96 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.52 | -78.42% |
US
|
|
| $0.02 | -99.22% |
HK
|
